Literature DB >> 18313595

The atrioventricular delay of cardiac resynchronization can be optimized hemodynamically during exercise and predicted from resting measurements.

Zachary I Whinnett1, Cathy Briscoe, Justin E R Davies, Keith Willson, Charlotte H Manisty, D Wyn Davies, Nicholas S Peters, Prapa Kanagaratnam, Alun D Hughes, Jamil Mayet, Darrel P Francis.   

Abstract

BACKGROUND: Atrioventricular (AV) optimization of cardiac resynchronization therapy (CRT) is typically calculated at rest. However, patients often become symptomatic during exercise.
OBJECTIVE: In this study, we use acute noninvasive hemodynamics to optimize the AV delay of CRT during exercise and investigate whether this exercise optimum can be predicted from a three-phase resting model.
METHODS: In 20 patients with CRT, we adjusted the sensed AV delay while the patient exercised on a treadmill up to a heart rate of 100 bpm to identify the hemodynamically optimal value. Separately, at rest, by pacing with three different configurations and calculating the sensed-paced difference, we calculated an "expected" value for the exercise optimum.
RESULTS: It was possible to perform AV delay optimization while a patient exercised. The resting three-phase model correlated well with the actual exercise optimal AV delay (r = 0.85, mean difference +/- standard deviation [SD] = 3.7 +/- 17 ms). Simply using measurements made at rest during atrial-sensed pacing showed a poorer correlation with exercise (r = 0.64, mean difference +/- SD = 2.2 +/- 24 ms). The three-phase resting model allows improved exercise hemodynamics to be achieved. Programming according to the three-phase resting model yields an exercise blood pressure of only 0.5 mmHg (+/-1.4 mmHg; P = NS) less than the true exercise optimum, whereas programming the resting sensed optimum yields an exercise blood pressure of 1.4 mmHg (+/-2.2 mmHg, P = .02) less than the true optimum.
CONCLUSIONS: Using acute noninvasive hemodynamics and a protocol of alternations, it is possible to optimize the AV delay of cardiac resynchronization devices even while a patient exercises. In clinical practice, the exercise optimum AV delay could be determined from three phases of resting measurements, without performing exercise.

Entities:  

Mesh:

Year:  2007        PMID: 18313595     DOI: 10.1016/j.hrthm.2007.11.019

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  9 in total

1.  Impact of moderate exercise workload on predicted optimal AV and VV delays determined by an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy.

Authors:  Margit Strauss; Torsten Becker; Thomas Kleemann; Ngoc Dyck; Frank Birkenhauer; Karlheinz Seidl
Journal:  Clin Res Cardiol       Date:  2010-06-02       Impact factor: 5.460

2.  Pacing at accelerated heart rate during echocardiography-guided atrioventricular optimisation following cardiac resynchronisation therapy.

Authors:  Daniel M Spevack; Amala Chirumamilla; Wilbert S Aronow
Journal:  Arch Med Sci Atheroscler Dis       Date:  2020-09-10

3.  SmartDelay determined AV optimization: a comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): rationale and design.

Authors:  Kenneth M Stein; Kenneth A Ellenbogen; Michael R Gold; Bernd Lemke; Ignacio Fernández Lozano; Suneet Mittal; Francis G Spinale; Jennifer E Van Eyk; Alan D Waggoner; Timothy E Meyer
Journal:  Pacing Clin Electrophysiol       Date:  2009-10-10       Impact factor: 1.976

4.  The acute effects of changes to AV delay on BP and stroke volume: potential implications for design of pacemaker optimization protocols.

Authors:  Charlotte H Manisty; Ali Al-Hussaini; Beth Unsworth; Resham Baruah; Punam A Pabari; Jamil Mayet; Alun D Hughes; Zachary I Whinnett; Darrel P Francis
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-11-17

Review 5.  Cardiac resynchronization therapy is certainly cardiac therapy, but how much resynchronization and how much atrioventricular delay optimization?

Authors:  Andreas Kyriacou; Punam A Pabari; Darrel P Francis
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

6.  Shortening of atrioventricular delay at increased atrial paced heart rates improves diastolic filling and functional class in patients with biventricular pacing.

Authors:  Reza Rafie; Salima Qamruddin; Ali Ozhand; Nima Taha; Tasneem Z Naqvi
Journal:  Cardiovasc Ultrasound       Date:  2012-01-24       Impact factor: 2.062

7.  Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally.

Authors:  Andreas Kyriacou; Punam A Pabari; Jamil Mayet; Nicholas S Peters; D Wyn Davies; P Boon Lim; David Lefroy; Alun D Hughes; Prapa Kanagaratnam; Darrel P Francis; Zachary I Whinnett
Journal:  Int J Cardiol       Date:  2013-10-16       Impact factor: 4.164

8.  Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function.

Authors:  Siana Jones; Joost Lumens; S M Afzal Sohaib; Judith A Finegold; Prapa Kanagaratnam; Mark Tanner; Edward Duncan; Philip Moore; Francisco Leyva; Mike Frenneaux; Mark Mason; Alun D Hughes; Darrel P Francis; Zachary I Whinnett
Journal:  Europace       Date:  2017-07-01       Impact factor: 5.214

9.  British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.

Authors:  Zachary I Whinnett; S M Afzal Sohaib; Siana Jones; Andreas Kyriacou; Katherine March; Emma Coady; Jamil Mayet; Alun D Hughes; Michael Frenneaux; Darrel P Francis
Journal:  BMC Cardiovasc Disord       Date:  2014-04-03       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.